Kim Theilgaard-Mønch
Clinical Associate Professor, Group leader
Department of Clinical Medicine
Blegdamsvej 9, 2100 København Ø
Theilgaard Group
Ole Maaløes Vej 5
2200 København N.
Member of:
ORCID: 0000-0002-4239-4939
1 - 1 out of 1Page size: 10
- 2010
- Published
A conceptual framework for the identification of candidate drugs and drug targets in acute promyelocytic leukemia
Marstrand, T. T., Borup, R., Willer, A., Borregaard, N., Sandelin, Albin Gustav, Porse, Bo Torben & Theilgaard-Mønch, Kim, Jul 2010, In: Leukemia. 24, 7, p. 1265-75 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 3997971
Most downloads
-
2493
downloads
HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
80
downloads
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
37
downloads
Phosphorylation of SHP2 at Tyr62 enables acquired resistance to SHP2 allosteric inhibitors in FLT3-ITD-driven AML
Research output: Contribution to journal › Journal article › Research › peer-review
Published